With a focus on tests, treatments, and a vaccine, we take a look at the emerging global clinical and economic evidence-base underpinning some of these technologies, the mechanisms (mostly global) for financing these commodities, and, finally, the decision-making processes for selecting technologies. This includes identifying the right subpopulations and negotiating a cost-effective tiered price across countries and regions.
CGD Policy Blogs
Before COVID-19, the 2014-2015 West African Ebola epidemic (EVD epidemic), was one of the most heavily modelled outbreaks in history. Within the first two months of the COVID-19 pandemic, 31 mathematical models were developed. Despite the clear differences in the two outbreaks, the EVD epidemic can help us draw lessons to improve COVID-19 modelling and its reach in policymaking. We discuss some of those learnings in this piece